China Universal Asset Management Co., Ltd. Beam Therapeutics Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,022 shares of BEAM stock, worth $354,568. This represents 0.03% of its overall portfolio holdings.
Number of Shares
17,022
Previous 17,794
4.34%
Holding current value
$354,568
Previous $441,000
24.72%
% of portfolio
0.03%
Previous 0.04%
Shares
16 transactions
Others Institutions Holding BEAM
# of Institutions
251Shares Held
93.5MCall Options Held
425KPut Options Held
309K-
Farallon Capital Management LLC San Francisco, CA9.93MShares$207 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.87MShares$185 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.48MShares$177 Million1.79% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$159 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$94.6 Million72.77% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.47B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...